v2.4.0.6
CONDENSED BALANCE SHEETS (USD $)
Mar. 31, 2012
Dec. 31, 2011
Current assets    
Cash and cash equivalents $ 1,855,193 $ 1,985,334
Prepaid research and development expenses 9,440 19,888
Other receivable   493,855
Other prepaid expenses and current assets 147,451 31,897
Total current assets 2,012,084 2,530,974
Property and equipment, net 9,934 11,689
Security deposit 13,342 13,342
TOTAL ASSETS 2,035,360 2,556,005
Current liabilities    
Accounts payable 1,424,598 1,008,493
Accrued expenses 173,833 296,512
Total current liabilities 1,598,431 1,305,005
Deferred rent 13,900 14,472
TOTAL LIABILITIES 1,612,331 1,319,477
COMMITMENTS AND CONTINGENCIES      
STOCKHOLDERS' EQUITY    
Common stock - $0.001 par value: 40,000,000 shares authorized, 11,408,274 shares issued and outstanding at March 31, 2012 and December 31, 2011 11,408 11,408
Deferred stock issuances (146) (146)
Additional paid-in capital 44,269,480 44,172,818
Deficit accumulated during the development stage (43,857,713) (42,947,552)
TOTAL STOCKHOLDERS' EQUITY 423,029 1,236,528
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,035,360 $ 2,556,005